CBUS

Cibus, Inc.

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Cibus, Inc. (CBUS) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B-); its weakest is Profitability (D+). The rating has held at C+ for 7 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
B-
Factor Score 2.9 / 5.0
Growth
B-
Factor Score 3.1 / 5.0
Profitability
D+
Factor Score 1.7 / 5.0
Momentum
C
Factor Score 2.4 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -1.8
EV / EBITDA -7.2
Rev Growth YoY 6.5%
Gross Margin N/M
Price Return 3M -39.4%
Price Return 12M -12.6%
Catalyst Signal 0.00
Market Cap $87.5M
TTM Revenue $4.3M
Price / Sales 20.1
ROE -223.2%

Historical Factor Score Progression

Held C+ for 7 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 B- (2.9) B- (3.1) D+ (1.7) C (2.4) C+ (2.6) C+ (2.6)
2026-11-04 B- (2.9) B- (3.1) D+ (1.8) C (2.4) C+ (2.7) C+ (2.6)
2026-10-28 B- (2.9) B- (3.1) D+ (1.8) C (2.2) C+ (2.7) C+ (2.5)
2026-10-21 B- (2.9) B- (3.1) D+ (1.7) C (2.3) C+ (2.6) C+ (2.5)
2026-10-14 B- (2.9) B- (3.1) D+ (1.7) C (2.2) C+ (2.6) C+ (2.5)
Page 1 of 4